EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Human antibodies as emerging drugs for antimicrobial resistance

Matteo Ridelfi, Vittoria Zucconi Galli Fonseca, Claudia Sala, Rino Rappuoli

Trends in Immunology · 2026-11 · 47 (11) · 1030-1044

DOI: 10.1016/j.it.2026.04.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2026-11. Verfasst von Matteo Ridelfi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Drug Resistance, Bacterial, Bacterial Infections, Bacteria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Intramural NIH HHS, European Research Council, Centre national des arts plastiques.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalDrug Resistance, BacterialBacterial InfectionsBacteriaAnti-Bacterial AgentsDrug Resistance, MicrobialHumansAnimals

Stichwörter der Autor:innen

antimicrobial resistancemonoclonal antibodiesprecision medicinesuperbugs

Substanzen

Antibodies, MonoclonalAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Fondazione Biotecnopolo di Siena, Siena, Italy.
  • Fondazione Biotecnopolo di Siena, Siena, Italy. Electronic address: rino.rappuoli@biotecnopolo.it.

Förderung

  • Intramural NIH HHS
  • European Research Council
  • Centre national des arts plastiques

Zitieren

APA

Ridelfi, M., Zucconi Galli Fonseca, V., Sala, C., & Rappuoli, R. (2026). Human antibodies as emerging drugs for antimicrobial resistance. Trends in Immunology, 47(11), 1030-1044. https://doi.org/10.1016/j.it.2026.04.003

Vancouver

Ridelfi M, Zucconi Galli Fonseca V, Sala C, Rappuoli R. Human antibodies as emerging drugs for antimicrobial resistance. Trends in Immunology. 2026;47(11):1030-1044. doi:10.1016/j.it.2026.04.003

BibTeX
@article{Ridelfi2026,
  author = {Ridelfi, Matteo and Zucconi Galli Fonseca, Vittoria and Sala, Claudia and Rappuoli, Rino},
  title = {Human antibodies as emerging drugs for antimicrobial resistance},
  journal = {Trends in Immunology},
  year = {2026},
  volume = {47},
  number = {11},
  pages = {1030--1044},
  doi = {10.1016/j.it.2026.04.003}
}
Kostenlos starten →